OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases May 9, 2022
ASN Kidney Week 2021 Oral abstract presentation- Initial Evaluation of High-Dose Extended-Release Calcifediol (ERC) in Patients with Stage 5 CKD on Hemodialysis (HD) Nov 5, 2021
Pituitary Society Presentation - Update on Somatrogon Development for the Treatment of Growth Hormone Deficiency in Pediatric and Adult Subjects Oct 28, 2020
Replay of the Evercore ISI COVID Dx Webinar with OPKO and BioReference Senior Leadership May 27, 2020
OPKO Announces the Publication of Two Abstracts In the Journal of the Endocrine Society Regarding the Global Phase 3 Somatrogon Pediatric Trial May 15, 2020
